Skip to main content

Table 4 Characteristics of the male sub-sample with gene expression profiling and cholesterol efflux measurements compared with male control subjects

From: Severe hypertriglyceridemia in Norway: prevalence, clinical and genetic characteristics

  Hypertriglyceridemia Controls p-values
n = 6 n = 9  
Age (years) 44 (32-50) 52 (25-60) 0.41
Total cholesterol (mmol/L) 8.9 (5.2-14.6) 4.5 (3.7-5.6) 0.004
LDL cholesterol (mmol/L) 2.3 (1.9-3.8) 2.9 (2.0-4.1) 0.41
HDL cholesterol (mmol/L) 1.4 (0.8-2.4) 1.5 (1.1-2.0) 0.63
Triglycerides (mmol/L) 17.3 (5.1-58) 0.7 (0.4-1.5) 0.001
Apolipoprotein A1 (mg/L) 1.1 (1.1-1.4) 1.5 (1.1-1.7) 0.019
Apolipoprotein B (mg/L) 0.8 (0.7-1.1) 0.8 (0.6-1.1) 0.58
Free fatty acids (nmol/L) 593 (372-798) 387 (172-681) 0.090
Hs-CRP (mg/L) 2.4 (0.7-20) 1.1 (0.7-2.8) 0.20
Glucose (mmol/L) 10.1 (5.5-14.7) 5.0 (4.4-5.4) 0.001
  1. Data are presented as median (range)
  2. Hs-CRP high sensitivity C-reactive protein